ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 272 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,527 | +10.3% | 429 | +46.4% | 0.00% | 0.0% |
| Q2 2023 | $10,448 | +112.0% | 293 | +51.0% | 0.00% | 0.0% |
| Q1 2023 | $4,928 | -81.8% | 194 | -71.0% | 0.00% | -66.7% |
| Q4 2022 | $27,094 | +12.9% | 668 | -8.0% | 0.00% | -25.0% |
| Q3 2022 | $24,000 | -4.0% | 726 | +1.0% | 0.00% | 0.0% |
| Q2 2022 | $25,000 | -24.2% | 719 | +0.1% | 0.00% | -20.0% |
| Q1 2022 | $33,000 | -56.6% | 718 | -37.2% | 0.01% | -58.3% |
| Q4 2021 | $76,000 | +7500.0% | 1,144 | +10300.0% | 0.01% | – |
| Q3 2021 | $1,000 | -92.9% | 11 | -94.8% | 0.00% | -100.0% |
| Q1 2021 | $14,000 | -67.4% | 213 | -78.7% | 0.00% | -75.0% |
| Q3 2020 | $43,000 | – | 1,000 | – | 0.01% | – |
| Q2 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q4 2019 | $33,000 | -21.4% | 515 | -65.7% | 0.01% | -31.2% |
| Q3 2019 | $42,000 | +7.7% | 1,500 | 0.0% | 0.02% | +6.7% |
| Q2 2019 | $39,000 | -46.6% | 1,500 | -62.5% | 0.02% | -48.3% |
| Q1 2019 | $73,000 | +40.4% | 4,000 | -4.8% | 0.03% | +11.5% |
| Q4 2018 | $52,000 | – | 4,200 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,303 | $54,386,000 | 28.54% |
| JOHNSON & JOHNSON | 3,260,869 | $216,196,000 | 24.61% |
| ACT CAPITAL MANAGEMENT, LLC | 210,500 | $13,956,000 | 10.09% |
| Aquilo Capital Management, LLC | 700,426 | $46,438,000 | 5.27% |
| WEALTH EFFECTS LLC | 145,960 | $9,677,000 | 4.02% |
| Evolutionary Tree Capital Management, LLC | 115,580 | $7,663,000 | 3.68% |
| ACUTA CAPITAL PARTNERS, LLC | 105,500 | $6,995,000 | 2.94% |
| Privium Fund Management B.V. | 204,393 | $13,766,000 | 2.73% |
| L1 Capital Pty Ltd | 292,735 | $19,408,000 | 2.24% |
| Avidity Partners Management LP | 875,000 | $58,013,000 | 1.23% |